Diabetes Board decisions

The veteran's service-connected disabilities, singly or in combination, do not preclude him from obtaining or maintaining any form of substantially gainful employment consistent with his education and industrial background.

The veteran's claims for higher initial ratings were denied as the evidence did not support a finding of entitlement to increased evaluations.

The veteran's claims for service connection for diabetes mellitus, Type II and hypertension were reopened based on new evidence. Service connection was granted for diabetes mellitus due to presumed exposure to Agent Orange.

The veteran's claims for an earlier effective date, a higher rating for diabetes mellitus, type II, and service connection for hypertension and bilateral leg disorder were denied.

The veteran's service-connected diabetes mellitus is rated at 20 percent, and the Board found that a higher rating was not warranted based on the evidence of record.

The veteran's diabetes mellitus is rated at 40 percent due to the need for insulin, a restricted diet, and regulation of activities.

The Board has reopened the claims for service connection for heart disability and hypertension, but denied service connection for type II diabetes mellitus and urticaria.

The Board denied service connection for diabetes mellitus, residuals of a heart attack, and residuals of a stroke as there was no evidence of these conditions in service or within the applicable presumptive period, nor any competent evidence linking them to the veteran's active duty service.

The Board denied the veteran's claims for service connection for diabetes mellitus and muscle pain and cramps in the calves due to an undiagnosed illness, as well as a higher rating for blepharitis.

The veteran does not have a current disability manifested by diabetic retinopathy that is caused or made worse by his service-connected diabetes mellitus.

The veteran's diabetes mellitus is not shown to require more than a 40 percent evaluation, as it does not meet the criteria for higher ratings based on episodes of ketoacidosis or hypoglycemic reactions requiring hospitalization or frequent visits to a diabetic care provider.

The Board denied the veteran's claims for service connection for Type II diabetes mellitus and erectile dysfunction, finding no evidence of a direct or secondary relationship to his military service.

The Board denied service connection for diabetes mellitus, and remanded the claims for residuals of cold injury to the hands and feet; a groin rash; and loss of two front teeth.

The Board denied the veteran's claims for an earlier effective date for the grant of service connection for chronic fatigue with depression and dysthymia, as well as for diabetic enteropathy.

The Board denied the restoration of a 10 percent rating for diabetes mellitus, type II, but granted a 10 percent rating for hypoglycemia as symptomatic of diabetes mellitus, type II, effective from February 13, 2008. The claim for an increased initial rating for tinnitus was denied.

The Board denied service connection for diabetes mellitus as it was not shown to be related to the veteran's military service, including any herbicide exposure.

The Board denied the veteran's claims for service connection for diabetes mellitus and heart disease as new and material evidence was not received to reopen these previously disallowed claims.

The Board denied the veteran's claims for service connection for diabetes mellitus, Type II, and hypertension, secondary to diabetes mellitus, due to exposure to Agent Orange because he did not serve in Vietnam and his service in Korea was prior to the recognized period of use of Agent Orange.

The Board granted service connection for multiple sclerosis on a presumptive basis, but denied service connection for CAD, diabetic retinopathy, and lower extremity edema with peripheral neuropathy.

The Board denied the veteran's claim for service connection for diabetes mellitus, type II, as there was no evidence of in-service exposure to Agent Orange or other herbicides and no evidence that the disease manifested within one year of discharge.